Trading Statement
ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049 JSE Code: AVL
TRADING STATEMENT
In terms of paragraph 3.4(b)(i) of the Listings Requirements of the JSE Limited, listed companies are required
to publish a trading statement as soon as they become reasonably certain that the financial results for the
next period to be reported on will differ by more than 20% from those of the comparative period.
The directors of Advanced Health hereby advise shareholders that, in respect of the reviewed consolidated
results for the period ended 31 December 2022, the Company expects a loss and headline loss per share from
continuing operations of 4.18 cents, 27% higher than the loss per share from continuing operations of 3.29
cents in the comparative period (prior year restated to exclude discontinued operations).
The information in this trading statement has not been reviewed and reported on by the Company’s auditors.
Pretoria.
31 March 2023
Designated Advisor
Grindrod Bank Limited
Date: 31-03-2023 02:10:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
